These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28104150)

  • 1. Comparison of Mizoribine and Mycophenolate Mofetil With a Tacrolimus-Based Immunosuppressive Regimen in Living-Donor Kidney Transplantation Recipients: A Retrospective Study in China.
    Shi Y; Liu H; Chen XG; Shen ZY
    Transplant Proc; 2017; 49(1):26-31. PubMed ID: 28104150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Mizoribine Combined With Tacrolimus in Living Donor Kidney Transplant Recipients: 3-Year Results by a Chinese Single Center Study.
    Shi Y; Liu H; Chen XG; Shen ZY
    Transplant Proc; 2019 Jun; 51(5):1337-1342. PubMed ID: 31155174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
    Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H;
    Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of a Quadruple Regimen Compared with Triple Regimens in Patients with Mycophenolic Acid-Related Gastrointestinal Complications After Renal Transplantation: A Short-Term Single-Center Study.
    Peng Z; Xian W; Sun H; Li E; Geng L; Tian J
    Ann Transplant; 2020 Feb; 25():e919875. PubMed ID: 32107364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation.
    Takahara S; Takahashi K; Akiyama T; Uchida K; Tanabe K; Amada N; Toma H
    Clin Exp Nephrol; 2013 Dec; 17(6):899-904. PubMed ID: 23430390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mizoribine versus mycophenolate mofetil in combination therapy with tacrolimus for de novo kidney transplantation: evaluation of efficacy and safety.
    Ju MK; Huh KH; Park KT; Kim SJ; Cho BH; Kim CD; So BJ; Kang CM; Lee S; Joo DJ; Kim YS
    Transplant Proc; 2013 May; 45(4):1481-6. PubMed ID: 23726602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
    Yoshimura N; Ushigome H; Matsuyama M; Nobori S; Suzuki T; Sakai K; Okajima H; Okamoto M
    Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation--a meta-analysis.
    Xing S; Yang J; Zhang X; Zhou P
    Clin Biochem; 2014 May; 47(7-8):663-9. PubMed ID: 24463228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness and safety of high-dose mizoribine on ABO-incompatible living related kidney transplantation using anti-CD20 and anti-CD25 antibodies without splenectomy: 3-year results.
    Yoshimura N; Ushigome H; Nobori S; Suzuki T; Sakai K; Koshino K; Nakamura T; Nakao T; Harada S; Ito T
    Transplant Proc; 2014; 46(2):391-4. PubMed ID: 24655971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of High-Dose Mizoribine Combined With Cyclosporine, Basiliximab, and Corticosteroids in Renal Transplantation: A Japanese Multicenter Study.
    Ushigome H; Uchida K; Nishimura K; Akioka K; Fukuda Y; Yuzawa K; Fujisawa M; Sugitani A; Ito SI; Nakatani T; Horimi T; Yoshimura N
    Transplant Proc; 2016 Apr; 48(3):794-8. PubMed ID: 27234738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of serum uric acid levels in response to the conversion from mycophenolate mofetil to mizoribine in kidney transplant recipients.
    Ding X; Zhu X; Zhang Y; Zhang L; Cheng M; Yu Y; Xu L; Li G
    Transplant Proc; 2013; 45(1):190-3. PubMed ID: 23375297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis.
    Chen J; Liu H; Yin W; Xu Z; Chen Z; Yiu W
    Comput Intell Neurosci; 2022; 2022():5717068. PubMed ID: 35909831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Mycophenolate Mofetil Associated With Tacrolimus for Kidney-pancreas and Kidney Transplantation: A Systematic Review and Meta-Analysis of Randomized Studies.
    Datrino LN; Boccuzzi ML; Silva RM; Castilho PHBT; Riva WJ; Rocha JS; Tustumi F
    Transplant Proc; 2024 Jun; 56(5):1066-1076. PubMed ID: 38853029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Inflammatory Syndrome Paradoxically Induced by De Novo Purine Inhibitors Synthesis Before Renal Transplantation: A Case Report and Review of the Literature.
    Maruyama Y; Sadahira T; Mitsui Y; Wada K; Tanimoto R; Nishimura S; Kobayashi Y; Watanabe T; Nasu Y; Araki M
    Transplant Proc; 2018 Apr; 50(3):895-897. PubMed ID: 29571743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excellent results of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids in renal transplant recipients--4-year results.
    Yoshimura N; Ushigome H; Nobori S; Suzuki T; Sakai K; Koshino K; Okajima H; Okamoto M
    Transplant Proc; 2013 May; 45(4):1472-5. PubMed ID: 23726600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beneficial effect of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids on CMV infection in renal transplant recipients.
    Yoshimura N; Ushigome H; Akioka K; Nobori S; Suzuki T; Sakai K; Okamoto M
    Clin Exp Nephrol; 2013 Feb; 17(1):127-33. PubMed ID: 23011290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Study of Mizoribine and Mycophenolate Mofetil Combined with a Calcineurin Inhibitor-Based Immunosuppressive Regimen in Patients with Alternative Donor Hematopoietic Cell Transplantation.
    Huang Y; Han M; Yang D; Zhang R; Ma Q; Pang A; Zhai W; He Y; Wei J; Jiang E; Feng S; Zhang L
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1663-1669. PubMed ID: 32504862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China.
    Li P; Cheng D; Wen J; Ni X; Xie K; Li X; Chen J
    BMC Nephrol; 2021 Oct; 22(1):328. PubMed ID: 34600511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.